Wobenzyme N
Presented promising discoveries about the role of systemic enzyme therapy for multiple myeloma patients.
Which are a continuation of the research she conducted at M.D. Anderson Cancer Center and the Institute of Tumor Biology in Vienna, revealed that Transforming Growth Factor beta (TGF-beta) levels in multiple myeloma patients are increased in the latter stages of cancer. This is significant because increased TGF-beta levels induce fibrosis, or hardening of tissue.
Complete
Line of
Wobenzyme-n Products
The encouraging news is studies show TGF-beta returned to normal levels when enzyme therapy was administered in addition to standard cancer therapies, such as radiation and/or chemotherapy. Normalizing TGF-beta levels is significant, as it is essential to avoiding the adverse effects of disease, such as fibrosis.
The systemic enzyme used in research is Wobe-Mugos, which evolved from Wobenzym(R)N, a German formula backed by nearly 50 years of scientific and clinical research. Wobe-Mugos has been used successfully in Europe in conjunction with chemotherapy since 1977. In 2000, the FDA granted Orphan Drug status of Wobe-Mugos as an adjunct therapy for multiple myeloma. A Phase III clinical trial was initiated in 2001 to corroborate its benefits, such as reducing the severity of symptoms, extending life span and improving quality of life.
Wobenzyme N Product
Since WobenzymN and Wobe-Mugos are so closely related, benefits such as improving tolerance of radiation and chemotherapy, better retention of nutrients and improved quality of life may also be expected of
Wobenzym. Currently, WobenzymN is used by millions worldwide to support joint health, promote robust circulation and to recover from sports-related injuries. In fact, WobenzymN has consistently outsold all over-the-counter products -- except aspirin -- in Germany. This product is available by prescription in the Czech Republic and Russia. In the U.S. it is available at health food stores.
Naturally Vitamins is the sole U.S. distributor of
WobenzymN. To learn more about WobenzymN, visit http://www.wobenzym.com/ .
|

|